Expanding the clinical and geographical spectrum of PARK-LRRK2 p.(Asn1437His): first report in a Swiss family
Year: 2026
Type: article
Study design: Case Report
Abstract: INTRODUCTION: Pathogenic variants in the LRRK2 gene represent the most common monogenic cause of Parkinson’s disease. Individual variants differ in frequency, geographical distribution and genotype-phenotype associations. Here, we report a Swiss family with multiple affected individuals carrying a very rare ROC-domain variant and provide a comprehensive characterisation of their clinical phenotype. CLINICAL FINDINGS: Age at onset was earlier than typically reported for PARK-LRRK2. Leg tremor was frequently the initial presenting symptom, followed by the development of an asymmetric akinetic-rigid syndrome with a clear dopaminergic response. Constipation was commonly reported, whereas significant cognitive symptoms were not evident. Notably, despite the high penetrance of the variant, disease progression was relatively mild. PRIMARY DIAGNOSIS: Genetic testing identified a heterozygous missense variant in the LRRK2 gene (c.4309A>C, p.(Asn1437His)), classified as likely pathogenic according to ACMG criteria. CONCLUSION: The present work expands both the geographical distribution of this rare ROC-domain variant and suggests that it may be associated with earlier onset but not necessarily greater disease severity. Continued characterisation of rare LRRK2 variants is essential for refining genotype-phenotype correlations and supporting emerging targeted therapies.
Source: Swiss Medical Weekly
DOI: 10.57187/5519
Institutions: University of Bern, University Hospital of Bern
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
Funders: Boston Scientific Corporation, Fondation Bertarelli, Institut National de la Santé et de la Recherche Médicale, Louis-Jeantet Foundation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Association France Parkinson, Fondation Roger de Spoelberch, Merz Pharmaceuticals, Parkinson Vereniging, Idorsia Pharmaceuticals, Parkinson Schweiz, St. Jude Medical
OpenAlex ID: W7234200784
